Bodi Envi blog, page 4
Plain, sourced writing on GLP-1 treatment: what the FDA-approved labels and the trials say, what compounded medication is and is not, what things cost, and how to choose a program.
- Guide
Tirzepatide and menopause
The Zepbound® label does not mention menopause. Who was in SURMOUNT-1 by sex and age, what a 2026 review says about sex and response, and what to ask.
- Guide
Tirzepatide side effects per the Zepbound® label
The side effects the Zepbound® label reports for tirzepatide by dose, when they occur, why, what a provider may do and when to seek care.
- Guide
Traveling with tirzepatide
What the Zepbound® label allows at room temperature, what the TSA says about medication at screening, and how to plan doses across a trip.
- Guide
Eating too little on a GLP-1 medication
What the labels warn about dehydration and kidney injury from reduced intake, what 2026 reviews report on meal size and muscle, and when to tell your provider.
- Guide
Eating well on tirzepatide, including plant based
What the Zepbound® label says about diet, what the Dietary Guidelines for Americans recommend, and what published reviews say about plant based eating.
- Guide
Not losing weight on tirzepatide: what to consider
How much results varied in SURMOUNT-1, what the Zepbound® label says about escalation and dose, what predicts response, and what to raise with a provider.
Start with an online assessment.
Answer a few questions about your health and goals. A licensed provider reviews your answers and decides whether treatment is appropriate for you.
